Eesti - eesti - Ravimiamet

galenpharma gmbh - prednisoloon - tablett - 50mg 50tk; 50mg 10tk

Eesti - eesti - Ravimiamet

panpharma gmbh - hüdroksükobalamiin - süstelahus - 1000mcg 1ml 1ml 10tk

Eesti - eesti - Ravimiamet

panpharma gmbh - droperidool - süstelahus - 2,5mg 1ml 1ml 10tk

Eesti - eesti - Ravimiamet

panpharma laboratories - streptomütsiin - süstelahuse pulber - 1000mg 50tk

Eesti - eesti - Ravimiamet

panpharma laboratories - naatriumhepariin - süstelahus - 5000rÜ 1ml 5ml 10tk

Eesti - eesti - Ravimiamet

panmedica - nefopaam - süste-/infusioonilahus - 20mg 2ml 2ml 10tk; 20mg 2ml 2ml 5tk

Euroopa Liit - eesti - EMA (European Medicines Agency)

esteve pharmaceuticals gmbh - zikonotiid - injections, spinal; pain - valuvaigistid - zikonotiid on näidustatud raske, kroonilise valu raviks patsientidel, kes vajavad intratekaalset (it) analgeesiat.

Euroopa Liit - eesti - EMA (European Medicines Agency)

esteve pharmaceuticals gmbh - tiotepa - hematopoietic stem cell transplantation; neoplasms - antineoplastilised ained - thiotepa riemser is indicated, in combination with other chemotherapy medicinal products:with or without total body irradiation (tbi), as conditioning treatment prior to allogeneic or autologous haematopoietic progenitor cell transplantation (hpct) in haematological diseases in adult and paediatric patients;when high dose chemotherapy with hpct support is appropriate for the treatment of solid tumours in adult and paediatric patients. thiotepa riemser is indicated, in combination with other chemotherapy medicinal products:with or without total body irradiation (tbi), as conditioning treatment prior to allogeneic or autologous haematopoietic progenitor cell transplantation (hpct) in haematological diseases in adult and paediatric patients;when high dose chemotherapy with hpct support is appropriate for the treatment of solid tumours in adult and paediatric patients.

Euroopa Liit - eesti - EMA (European Medicines Agency)

teva gmbh - dimetüülfumaraat - multiple sclerosis, relapsing-remitting; multiple sclerosis - immunosupressandid - dimethyl fumarate teva is indicated for the treatment of adult and paediatric patients aged 13 years and older with relapsing remitting multiple sclerosis (rrms).

Eesti - eesti - Ravimiamet

genericon pharma gmbh - olmesartaanmedoksomiil+hüdroklorotiasiid - õhukese polümeerikattega tablett - 20mg+12,5mg 56tk; 20mg+12,5mg 7tk; 20mg+12,5mg 100tk; 20mg+12,5mg 50tk; 20mg+12,5mg 90tk; 20mg+12,5mg 21tk; 20mg+12,5mg 10tk; 20mg+12,5mg 30tk; 20mg+12,5mg 98tk; 20mg+12,5mg 14tk